Medesthetics

MAR 2015

MedEsthetics magazines offers business education and in-depth coverage of the latest noninvasive cosmetic procedures for physicians and practice managers working in the medical aesthetics industry.

Issue link: https://medesthetics.epubxp.com/i/468544

Contents of this Issue

Navigation

Page 24 of 90

Restylane and Galderma are registered trademarks of Galderma S.A. © 2015 Galderma Laboratories, L.P. SLK-064 01/15 Important Safety Information Indication: Restylane Silk is indicated for submucosal implantation for lip augmentation and dermal implantation for correction of perioral rhytids in patients over the age of 21. Restylane Silk should not be used by people with previous bad allergies, particularly to microorganisms known as gram-positive bacteria, or by people with serious allergies to drugs that have previously required in-hospital treatment. Restylane Silk should not be used by people with bleeding disorders. Restylane Silk should not be used by anyone with a known allergy to lidocaine. Use at the site of skin sores, pimples, rashes, hives, cysts, or infection should be postponed until healing is complete. In these instances, product use could delay healing or make skin problems worse. After treatment, swelling, redness, pain, bruising, or tenderness may occur. Swelling may be more likely in patients under 36 years, and bruising may be more likely in patients over 35 years. Restylane Silk should not be injected into blood vessels. Treatment volume should be limited to 1.5 mL per lip per treatment and 1.0 mL for perioral rhytid correction, as greater amounts signifi cantly increase moderate and severe injection site reactions. Please see complete Instructions for Use at restylanesilk.com or restylaneusa.com.

Articles in this issue

Links on this page

Archives of this issue

view archives of Medesthetics - MAR 2015